In line with previous reports, TERT promoter mutations in our series as a whole were associated with older age at diagnosis, more advanced tumor stage, more frequent need for a second treatment, and worse outcomes (around 67% of patient had persistent disease or died of their disease). Here, TERT is linked to neoplasm.